Altimmune Inc

ALTNASDAQ · USD
3.26USD+0.02 (+0.47%)
159

Altimmune Inc (ALT) Option Chain

As of September 17, 2026, Altimmune Inc is trading at $3.26, a +0.47% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 123.5%. IV Rank is 45%.

Read more

Tracking the ALT option chain helps you see every strike and expiry on Altimmune Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Altimmune Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ALT options activity at a glance. Use our scanner to monitor the ALT option chain in real time and filter for the ALT options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ALT stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ALT option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ALT stock options are being actively traded and where they are not.

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc.

in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Altimmune Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ALT options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ALT stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile60.71% Neutral
  • Market cap (M$)630
  • 52 weeks high-49.69%
  • 52 weeks low26.56%
  • Analyst recommendationStrong Buy
    1.33
  • Target price$17.12
    425.96% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-05
  • P/E
  • Future P/E
  • EPS (ttm)-0.79
  • EPS growth next 5 years14.12%

As of September 17, 2026

2026-09-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.0027300.020.760.101.452.50-22.840.100.000.100117100.00
7.773,686260-0.030.260.200.253.00-7.410.050.000.0523,25392.23
92.998,06360.050.000.053.50+8.020.200.550.240.1351007.01
100.004,51500.050.000.054.00+23.460.251.200.74-0.020500.00
100.001,23200.050.000.054.50+38.890.951.351.24-0.09300.00

As of September 17, 2026

Scan the full option chain in one place

Browse the full ALT option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial